Detectable tumor cells in the blood and bone marrow: smoke or fire?

Development and validation of circulating tumour cell enumeration (Epic Sciences) as a prognostic biomarker in men with metastatic castration-resistant prostate cancer.

European journal of cancer (Oxford, England : 1990)·2021

Circulating tumour cell increase as a biomarker of disease progression in metastatic castration-resistant prostate cancer patients with low baseline CTC counts.

Annals of oncology : official journal of the European Society for Medical Oncology·2018

Periprostatic adipose inflammation is associated with high-grade prostate cancer.

Prostate cancer and prostatic diseases·2017

Androgen receptor mutations in patients with castration-resistant prostate cancer treated with apalutamide.

Annals of oncology : official journal of the European Society for Medical Oncology·2017

Collaborating to Compete: Blood Profiling Atlas in Cancer (BloodPAC) Consortium.

Clinical pharmacology and therapeutics·2017

A prognostic index model for predicting overall survival in patients with metastatic castration-resistant prostate cancer treated with abiraterone acetate after docetaxel.

Annals of oncology : official journal of the European Society for Medical Oncology·2015

Adjuvant CDK4/6 inhibitors in early-stage breast cancer: Clinical evidence and considerations for risk stratification and treatment selection.

Cancer·2026

The burden of male breast cancer (MBC) in the GBD Central, Eastern, and Western Europe Regions from 1990 to 2023: Results from the Global Burden of Disease Study 2023.

Cancer·2026

Racial differences in multiple myeloma survival: Associations with stem cell transplantation, insurance, and Medicaid expansion.

Cancer·2026

Cancer statistics for Asian American, Native Hawaiian, and Pacific Islander people, 2026.

Cancer·2026

Vimseltinib for patients with tenosynovial giant cell tumor: A multicenter, open-label, phase 2 trial.

Cancer·2026

Gynecologic cancers in low- and middle-income countries: Bridging the survival gap.

Cancer·2026

Light Source-Dependent Photooxidation of Therapeutic Monoclonal Antibodies: A Comparative Study of Light-Emitting Diode (LED) and Fluorescent Exposure.

Pharmaceutical development and technology·2026

Single-cell immune profiling of blood and thrombus in cancer-associated thrombosis.

iScience·2026

BCR::ABL1 e1a2 (p190)-Positive Myeloid Blast Neoplasm: Diagnostic Challenges in Distinguishing De Novo Acute Myeloid Leukemia From Previously Unrecognized Chronic Myeloid Leukemia in the Blast Phase.

Cureus·2026

Myeloid sarcoma as EM blast crisis in BCR-ABL1 e6a2+ CML with myelofibrosis and TB: a case report.

Open life sciences·2026

Long-term results of the HD0607 trial on interim PET-adapted treatment of advanced-stage Hodgkin lymphoma beyond 10 years of follow-up.

EClinicalMedicine·2026

Related Experiment Videos

Detectable tumor cells in the blood and bone marrow: smoke or fire?

Related Concept Videos

Development and validation of circulating tumour cell enumeration (Epic Sciences) as a prognostic biomarker in men with metastatic castration-resistant prostate cancer.

Circulating tumour cell increase as a biomarker of disease progression in metastatic castration-resistant prostate cancer patients with low baseline CTC counts.

Periprostatic adipose inflammation is associated with high-grade prostate cancer.

Androgen receptor mutations in patients with castration-resistant prostate cancer treated with apalutamide.

Collaborating to Compete: Blood Profiling Atlas in Cancer (BloodPAC) Consortium.

A prognostic index model for predicting overall survival in patients with metastatic castration-resistant prostate cancer treated with abiraterone acetate after docetaxel.

Adjuvant CDK4/6 inhibitors in early-stage breast cancer: Clinical evidence and considerations for risk stratification and treatment selection.

The burden of male breast cancer (MBC) in the GBD Central, Eastern, and Western Europe Regions from 1990 to 2023: Results from the Global Burden of Disease Study 2023.

Racial differences in multiple myeloma survival: Associations with stem cell transplantation, insurance, and Medicaid expansion.

Cancer statistics for Asian American, Native Hawaiian, and Pacific Islander people, 2026.

Vimseltinib for patients with tenosynovial giant cell tumor: A multicenter, open-label, phase 2 trial.

Gynecologic cancers in low- and middle-income countries: Bridging the survival gap.

Light Source-Dependent Photooxidation of Therapeutic Monoclonal Antibodies: A Comparative Study of Light-Emitting Diode (LED) and Fluorescent Exposure.

Single-cell immune profiling of blood and thrombus in cancer-associated thrombosis.

BCR::ABL1 e1a2 (p190)-Positive Myeloid Blast Neoplasm: Diagnostic Challenges in Distinguishing De Novo Acute Myeloid Leukemia From Previously Unrecognized Chronic Myeloid Leukemia in the Blast Phase.

Myeloid sarcoma as EM blast crisis in BCR-ABL1 e6a2+ CML with myelofibrosis and TB: a case report.

Long-term results of the HD0607 trial on interim PET-adapted treatment of advanced-stage Hodgkin lymphoma beyond 10 years of follow-up.

Related Experiment Videos

Detectable tumor cells in the blood and bone marrow: smoke or fire?

Related Concept Videos

Related Articles